Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early CNI Withdrawal and Rapamune Replacement in Kidney Transplant
NCT00121810Phase 4Completed
- Sponsor
- Roche
- Start
- Aug 2003
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in kidney transplantation (2 arms), sponsored by Roche. Primary endpoint: Mean Percent Change in Glomerular Filtration Rate at 12 months. Started Aug 2003; status: completed.
02
Drugs
sirolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00121810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00121810.